Zobrazeno 1 - 10
of 21
pro vyhledávání: '"James C. Blosser"'
Autor:
Sally A. McCreedy, Kris E. Kucera, David J. Triggle, Matthew Marler, Roberta Mihut, E. S. C. Wu, Jack Gordon, Mary L. Stagnitto, Dan Widzowski, Andrew Howell, Anthony C. Machulskis, John Zongrone, Paul Bialobok, George B. Mullen, Marilyn K. Knowles, Shawn Sitar, James C. Blosser
Publikováno v:
Drug Development Research. 40:117-132
The purpose of these studies was to determine the levels of intrinsic activity in vitro at muscarinic receptor pharmacological subtypes (M1, M2, and M3) that would optimize cognitive activity while minimizing acute adverse cholinergic effects in vivo
Autor:
Alexander Rochester New York Us Kover, James T. Loch, L.Paul Rosenberg, Simon F. Semus, John Zongrone, Anthony C. Machulskis, James C. Blosser, John C. Gordon, Patrick R. Verhoest, Sally A. McCreedy, Edwin S. C. Wu
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:2525-2530
To improve receptor binding affinity and to investigate functional selectivity of 2,8-dimethyl-1-oxa-8-azaspiro[4.5]decan-3-one acetylhydrazone 2 at muscarinic receptor subtypes, a series of acylhydrazones A was synthesized. The SAR indicates that th
Autor:
Alex Kover, Robert J. Murray, James C. Blosser, R. A. Mack, George B. Mullen, Sally A. McCreedy, James T. Loch, Anthony C. Machulskis, E. S. C. Wu, John C. Gordon
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:1813-1818
A short and efficient synthesis of both enantiomers of 2,8-dimethyl-1-oxa-8-azaspiro[4.5]-decan-3-one is described. The biological activity of the racemate resides predominantly in the S-enantiomer. While the S-isomer is a full M2-agonist, the R-isom
Autor:
James T. Loch, Robert J. Murray, James C. Blosser, Sally A. McCreedy, E. S. C. Wu, R. A. Mack, Anthony C. Machulskis, George B. Mullen, John C. Gordon, Alexander Rochester New York Us Kover
Publikováno v:
ChemInform. 26
Autor:
Louis R. Freedman, H. Steve White, Ranjit Ray, James C. Blosser, Sally A. McCreedy, Gene C. Palmer, George E. Garske, Ronald C. Griffith, Jose H. Woodhead, Eric W. Harris, Ewart A. Swinyard, Napier James J
Publikováno v:
Epilepsy Research. 9:161-174
Studies conducted by Fisons Pharmaceuticals and the Antiepileptic Drug Development Program (ADD Program) of the Epilepsy Branch (NINDS, NIH) revealed that ‘remacemide’ (FPL 12924, formerly PR 934-423) was effective orally in the prevention of max
Publikováno v:
Drug Development Research. 40:101-103
Autor:
Ronald C. Griffith, Robert J. Murray, George B. Mullen, Anthony C. Machulskis, Sally A. McCreedy, James C. Blosser, Edwin S. C. Wu, James T. Loch, Alex Kover
Publikováno v:
Journal of medicinal chemistry. 38(9)
The cholinergic hypothesis of Alzheimer's disease suggests that cholinergic agonists may have therapeutic potential for treating the attendant memory deficits of the disease. As part of a program aimed at preparing metabolically stable, nonquaternary
Autor:
M. A. Dailey, T. L. Thomas, T. A. Davidson, T. E. Cole, A. R. Borrelli, M. Fedorchuk, E. S. C. Wu, James C. Blosser, K. G. Doring, J T Loch rd
Publikováno v:
Journal of Medicinal Chemistry. 32:183-192
(3-Phenyl-7-flavonoxy)propanolamines have been shown to exhibit antihypertensive activity in spontaneously hypertensive rats. Although they are structurally similar to classical beta-adrenergic blocking compounds, their activity is not due to inhibit
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 720:28-35
The inhibition of membrane depolarization by tetrodotoxin or the local anesthetic benzocaine elevates the acetylcholine receptor levels in cultured myotubes. The elevated acetylcholine receptor levels are due to increased receptor synthesis rather th
Publikováno v:
Annals of the New York Academy of Sciences. 377:189-197